Pharmaceutical Supply – Nitroglycerin Tablets

The contract outlines the manufacture and supply of Nitroglycerin Tablets, identified by NSN 650501153379 and NDC NDC00071-0418-13, under strict compliance with FDA current Good Manufacturing Practices, Department of Defense Logistics Agency labeling requirements, and all applicable federal pharmaceutical standards. The product is being procured as part of a subcontract awarded by the Defense Logistics Agency under the Department of Defense, ensuring the tablets meet rigorous quality and safety benchmarks for military and federal use. Production and delivery must adhere to established regulatory frameworks governing pharmaceuticals distributed through government channels. The contract was posted on July 14, 2026, and is tied to the procurement vehicle SPE2DX25D9900 with delivery order SPE2DP26F7511, under NAICS code 325412 for pharmaceutical and biological product manufacturing. While specific quantities and delivery timelines are not detailed in the provided data, the supply is intended to support federal supply chains requiring standardized, high-integrity medications. All manufacturing and labeling activities must align with DLA specifications, ensuring traceability, consistency, and readiness for distribution to authorized federal facilities. The contract emphasizes compliance over cost, prioritizing regulatory adherence and product reliability in a strategic medical supply context.